Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P180001/S017

Zenith Fenestrated AAA Endovascular Graft

William Cook Europe Aps · Decision date May 21, 2026

FDA DECISIONP180001/S017

What did the FDA decide?

FDA records P180001/S017 as a supplement to PMA P180001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 21, 2026.

FDA approval order statement

approval for a new supplier for a component of delivery systems of the Zenith (Flex) AAA Endovascular Graft, Zenith Renu AAA Ancillary Graft, Zenith Fenestrated AAA Endovascular Graft, Zenith Alpha & Alpha2 Thoracic Endovascular Graft, Zenith Dissection Endovascular System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
May 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P180001/S017
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
OK30
Decision date
May 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P180001/S017 received

    Application receipt date recorded by FDA.

  2. P180001/S016 · Related supplement

    Zenith Dissection Endovascular System

  3. P180001/S017 · FDA decision

    30-Day Notice

  4. P180001/S018 · Related supplement

    Zenith Dissection Endovascular System (ZDEG/ZDES)

Timeline entries are records held by MedtechLedger for P180001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180001

Product / regulatory recordCompanyPathwayDecision dateSource
William Cook Europe ApsPMA supplementMay 8, 2026FDA
William Cook Europe ApsPMA supplementAug 4, 2026FDA

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

William Cook Europe Aps

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sandet 6, Dk-4632, Bjaeverskov

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records